• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services


  • Print
  • Share
  • E-mail

Section Contents Menu

Drug Safety and Availability

FDA Drug Safety Newsletter - Volume 1, Number 1, Fall 2007

This publication provides postmarketing information to healthcare professionals to enhance communication of new drug safety information, raise awareness of reported adverse events, and stimulate additional adverse event reporting.

In This Issue

Welcome from the Commissioner

Editor's Note

Postmarketing Reviews

New Molecular Entity (NME) - Early Safety Findings

Drug Safety Communications

 doctor holding baby, test tubes, pills coming out of a vial